In case you haven’t heard, health tech entrepreneurs are taking NYC by storm. For their 5th demo day, Blueprint Health, a major player at the epicenter of this movement, attracted a legion of industry heavy-hitters like Pfizer, Aetna, and McKinsey. With over 700 people packing the room to check out the latest class of accelerated startups, Blueprint Health is weaving together a community of mentors, investors, and entrepreneurs all passionate about building innovative solutions to healthcare system challenges.
With doctors, serial entrepreneurs, former Googlers, and experienced consultants, this round’s class of 20 entrepreneurs is launching seven new companies, aptly described by Blueprint alumnus, Peter Bechtel, as, “golden nuggets waiting to explode.”
Click here to learn more about the startups in order of appearance
MediQuire helps hospitals measure and improve clinician performance. In addition to supporting hospitals in the development and management of clinical metrics, MediQuire delivers personalized action plans that tell clinicians where and how to improve. MediQuire even takes it a step further by generating snapshots of performance at the provider level. This dashboard allows practitioners to see how they perform against their peers (a strong motivator) and helps hospitals identify and disseminate best practices.
RubiconMD gives primary care physicians a simple way to bring specialist expertise into the primary care setting. Through their tool, primary care physicians can submit questions and medical imaging to a selected specialist and receive a response in a matter of hours. Avoiding the complex and inefficient referral process, this streamlined system saves patients and providers time and money. With the announcement of new client Qliance, a leading innovator in direct primary care with over 32,000 patients, RubiconMD is clearly quickly gaining traction.
Twiage is out to save lives by improving communications between ambulances and hospital emergency rooms. Replacing the current two-way radio equipment with a secure HIPAA-compliant dashboard, Twiage seamlessly connects emergency medical services to emergency departments, improving overall communication and helping hospitals cut costs.
CEO
Decisive Health
Decisive Health helps specialists and patients work together to more effectively and efficiently select treatment options. Through Decisive Health, patients receive education modules on treatment options, risks, and benefits, prior to meeting with a physician. Patients also complete surveys that help providers match treatment options to patient preferences. By helping specialists engage patients in the decision-making process and tailor treatments to patient needs, Decisive Health cuts costs and improves health outcomes.
BoardRounds manages the sticky post-discharge process. Using the BoardRounds mobile application, patients can find and schedule follow up services. Physicians can also access the tool through their electronic medical records. In addition to scheduling, the BoardRounds’ analytics platform helps physicians select the most appropriate post-discharge interventions and identify high-risk patients.
Pulsebeat is a 21st century home healthcare solution. The only direct-to-consumer company in the group, Pulsebeat, is jumping on the booming sensor and self-tracking movement and offering a remote monitoring system for aging loved ones. With Pulsebeat, caregivers receive a daily report card of their loved one’s health and are able to dispatch home health aids at a moment’s notice.
ProofPilot is an easy-to-use platform for designing, launching, and managing research studies and clinical trials—think TurboTax for clinical trials. Introduced by Pfizer’s Head of Clinical Innovation within Worldwide Research & Development, Craig Lipset, as an “oasis,” ProofPilot is bringing the promise of tech innovation to the pharmaceutical market—a piece of the healthcare industry that has remained relatively “undisrupted,” until now. With the platform already turning a profit, the team projects hitting $1 million in revenue by the end of this year.
